Aarti Drugs Ltd reported their audited financial results for the quarter and half-year ended September 30, 2025, approved by the Board on November 7, 2025. The company also completed a buyback of 650,000 equity shares, representing 0.72% of total equity, and commenced operations at a new manufacturing plant in Gujarat on September 4, 2025.